Form 4: Bioxytran Director Radka Milanova Reports Acquisition and Disposal of Preferred Stock

Radka Milanova, a director at Bioxytran, Inc., reported acquiring and disposing of preferred stock on October 25, 2024.

Summary

• On October 25, 2024, Radka Milanova, a director of Bioxytran, Inc. (BIXT), reported a transaction involving the company's preferred stock.
• Milanova acquired 20,619 shares of preferred stock at a price of $0.46 per share.
• Following the reported transaction, Milanova's beneficial ownership of the securities is 57,148 shares.

Sentiment

Score: 5

Explanation: This is a neutral report of insider trading activity, with no clear positive or negative implications.

Industry Context

This Form 4 filing is a routine disclosure required by the SEC for corporate insiders, providing transparency into their trading activities in the company's stock.

Stakeholder Impact

• The transaction may be of interest to shareholders as it provides insight into the trading activities of a company director.

Key Dates

Keywords

Bioxytran, BIXT, Radka Milanova, preferred stock, Form 4, director, acquisition, disposal, beneficial ownership, transaction